Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

M Schmitt; OG Wilhelm; G Schricker; R Napieralski; John Martens; M Aubele; M Kiechle

doi:10.1159/000493016

Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

M Schmitt, OG Wilhelm, G Schricker, R Napieralski, John Martens, M Aubele, M Kiechle

Medical Oncology

Research output: Contribution to journal › Article › Academic

6 Citations (Scopus)

4 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	425-433
Number of pages	9
Journal	Breast Care
Volume	13
Issue number	6
DOIs	https://doi.org/10.1159/000493016
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000493016

REPUB_110703-OA.pdfFinal published version, 533 KB

http://hdl.handle.net/1765/110703

Cite this

@article{2c1baad8fa864a0084083aef954053cb,

title = "Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy",

author = "M Schmitt and OG Wilhelm and G Schricker and R Napieralski and John Martens and M Aubele and M Kiechle",

year = "2018",

doi = "10.1159/000493016",

language = "Undefined/Unknown",

volume = "13",

pages = "425--433",

journal = "Breast Care",

issn = "1661-3791",

publisher = "Karger",

number = "6",

}

TY - JOUR

T1 - Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy

AU - Schmitt, M

AU - Wilhelm, OG

AU - Schricker, G

AU - Napieralski, R

AU - Martens, John

AU - Aubele, M

AU - Kiechle, M

PY - 2018

Y1 - 2018

U2 - 10.1159/000493016

DO - 10.1159/000493016

M3 - Article

SN - 1661-3791

VL - 13

SP - 425

EP - 433

JO - Breast Care

JF - Breast Care

IS - 6

ER -